 HANOVER, MD, March 10, 2022 GLOBE NEWSWIRE -- Processa Pharmaceuticals, Inc. NASDAQ: PCSA, Processa or the Company, a clinical-stage biopharmaceutical company developing products to improve the survival andor quality of life for patients who have unmet medical need conditions, announced today that the Companys CEO Dr. David Young, will present at the Oppenheimer 32nd Annual Healthcare Conference on March 17th, 2022 at 10:00 AM Eastern. 